Skin Aging: Physiology and Management

(MD Dermatology Theory Notes — based on Fitzpatrick's Dermatology, 9th ed., Chapter 106: "Skin Aging")

---

1. Definitions and Classification

• Elderly = chronologic age >65 years (WHO definition; accepted in Westernized countries).
• By 2050 the elderly population is projected to more than double in developing countries.

---

2. Theories/Mechanisms of Aging — Oxidative Stress

• One major theory: aging results from cellular senescence/apoptosis secondary to oxidative damage.
• Reactive oxygen species (ROS) are a normal by-product of aerobic metabolism; the skin has an enzymatic + non-enzymatic antioxidant defense system that counteracts them, but this defense weakens with age, tipping the balance toward oxidative stress.
• Oxidative damage → upregulation of stress-related transcription factors (hypoxia-inducible factors, NF-κB) → induction of pro-inflammatory cytokines (IL-1, IL-6, VEGF, TNF-α) → these act as regulators of cell survival and modulators of matrix-degrading metalloproteinases (MMPs).
• Oxidative damage to proteins + age-related decline in proteasome activity → accumulation of damaged/dysfunctional proteins.
• Telomere shortening: Telomeres are terminal tandem-repeat DNA sequences protecting chromosome ends; they shorten with each somatic division (DNA polymerase cannot replicate the terminal base pairs). When telomeres reach a "critically short" threshold → cell undergoes proliferative (replicative) senescence or apoptosis (p53-mediated) — Fig. 106-2.
  • Cellular senescence is considered a tumor-suppressor mechanism preventing unchecked proliferation of mutated cells — a biological trade-off between longevity and cancer risk.
  • Improved DNA repair correlates with longer lifespan across mammalian species.

---

3. Intrinsic Skin Aging

• Features: decreased collagen production, reduced cutaneous blood flow, lowered lipid content, loss of rete ridges.
• Clinical result: dry, pale skin with fine wrinkles, decreased elasticity, impaired reparative (wound-healing) capacity.
• Associated with development of benign neoplasms due to impaired regulation of cellular proliferation.

---

4. Extrinsic Skin Aging / Photoaging

• Extrinsic aging = physiologic + structural changes from environmental exposure; UV radiation (photoaging) is the most important cause.
• Other contributors: cigarette smoking, diet, chemical exposure, trauma, air pollutants (particulate matter, CO, CO₂, SO₂, NOₓ).
  • Cross-sectional German study: chronic traffic-related particulate matter exposure associated with premature aging and pigment spots.
  • Indoor air pollution (cooking with fossil fuels) linked to accelerated aging (Chinese cohort).
  • Aryl hydrocarbon receptor activation by tobacco smoke/particulates implicated in extrinsic aging.
  • Ozone: causes skin inflammation, disrupts barrier via lipid peroxidation and protein oxidation in stratum corneum.
• Solar spectrum reaching skin: UV, visible, and infrared.
  • Infrared A (700–1400 nm) penetrates to the hypodermis, increases ROS production, impairs mitochondrial integrity.
  • Infrared B (1400–3000 nm) and Infrared C (3000 nm–1 mm) do not penetrate well.

Histologic and Clinical Comparison (Table 106-2)

---

5. Estrogen and Skin Aging

• Estrogens are important regulators of skin physiology and wound healing (act via estrogen receptors as ligand-activated transcription factors; modulate redox balance/oxidative stress).
• Topical conjugated estrogen cream on photoaged facial skin → increased skin thickness, decreased fine wrinkles.
• Topical estradiol induces procollagen in sun-protected skin (postmenopausal women, age-matched men) but not in photoaged skin — suggests chronic UV damage impairs estrogen's ability to stimulate collagen synthesis, and the effect is likely non-genomic/indirect (independent of classic ER signaling).
• Estrogen effects on skin structures (Table 106-3): influences epidermal turnover/permeability barrier, sebaceous/apocrine gland activity, and hair follicle cycling (may inhibit follicular melanocyte activity); associated with morphologic improvement of collagen/elastic fibers.

---

6. Epidermal Changes with Aging

• Epidermal turnover rate decreases by ~30–50% between the 3rd and 8th decades.
• Barrier: abnormal permeability barrier homeostasis, decreased stratum corneum integrity, decreased filaggrin → increased dryness/scaliness.

Cell-type-specific changes (Table 106-4)

• Collagen synthesis downregulation with age and photodamage; aging fibroblasts have reduced collagen-synthetic capacity.
• MMP dynamics: acute UV transiently upregulates MMP-1, MMP-3, MMP-9 (epidermis-derived); chronically photodamaged skin constitutively expresses higher levels of 7 MMPs (MMP-1, -2, -3, -9, -11, -17, -27), mainly fibroblast-derived → collagen fragmentation → fragmented collagen fails to provide mechanical tension needed to stimulate fibroblast collagen synthesis → vicious cycle of increased degradation + decreased production.

---

7. Dermal Changes with Aging (Table 106-5)

---

8. Appendageal / Adnexal Changes

• Nails: more brittle, ridging (altered lipid composition).
• Glands: decreased number and output of eccrine glands → reduced sweating → increased vulnerability to heat stroke; reduced size/function of apocrine glands; sebaceous gland size/number relatively constant but sebum production declines (hormonal).
• Hair: paradoxical increase of coarse hair at nostrils, ears, eyebrows (men) and chin/upper lip (women) despite scalp thinning elsewhere.
• Nerves: increased tactile thresholds (decreased size/density of Pacinian and Meissner corpuscles); increased thermal pain thresholds; decline in spatial acuity (2-point discrimination, light touch, vibration).

---

9. Geriatric Dermatoses (Clinical Manifestations)

A. Benign growths

• Solar (senile) lentigines — UV-related, increased melanin production + abnormal keratinocyte proliferation/differentiation.
• Seborrheic keratoses — waxy/wart-like papules/plaques, prevalence 8–54% in elderly; UV-independent (unlike lentigines); result of impaired focal epidermal homeostasis → clonal melanocyte/keratinocyte expansion; keratinocyte-derived endothelin-1 implicated; no malignant potential; treat only for cosmetic reasons/bleeding.
• Senile (cherry) angiomas.

B. Malignant skin lesions

• Skin cancer incidence rises exponentially with age; represents ~40% of malignancies diagnosed in the elderly.
• Elderly males: thicker melanomas, higher mortality vs age-matched women/younger men.
• BCC is the most common; SCC carries greater nonmelanoma-related morbidity/mortality.
• Angiosarcoma — head/neck, enlarging nonblanching violaceous patch/nodule with ulceration; high VEGF/VEGFR-2 (potential therapeutic targets).
• Kaposi sarcoma (KS) — HHV-8 associated; classic KS mainly affects Eastern European Jewish/Mediterranean men; purple/red/brown macules-plaques-nodules on face/lower limbs; can involve lung/liver/GI (obstruction, bleeding).

C. Xerosis, Asteatotic Eczema, Pruritus

• Xerosis: dry skin from decreased lipids/barrier function — very common in elderly.
• Asteatotic eczema ("eczema craquelé"): xerosis complicated by dermatitis — dry, pruritic, fissured, scaly plaques; typically winter/low-humidity heated environments; managed like xerosis (behavioral/environmental modification + topical emollients).
• Pruritus: common, major QoL impact; causes include xerosis, but also scabies/pediculosis (treat with malathion, lindane, or permethrin; oral ivermectin for scabies), cutaneous larva migrans, cutaneous leishmaniasis.

D. Infections in the Elderly

• Bacterial: impetigo and folliculitis often staphylococcal; cellulitis (strep/staph) may present subtly; risk factors — diabetes, immunodeficiency, lymphedema, chronic venous insufficiency; watch for orbital cellulitis (contiguous sinus spread or metastatic).
• Fungal: increased risk from age-related immune decline, vitamin deficiency, peripheral vascular disease, antibiotic use, lymphoproliferative disorders; dermatophyte infections (tinea capitis/corporis/pedis/unguium) — tinea pedis affects ~80% of patients >60 years, often complicated in diabetics.
• Viral: VZV and HSV — vermilion lip border most common HSV site in elderly; recurrent herpes labialis can autoinoculate eye/genital area; treat with acyclovir, famciclovir, valacyclovir.

E. Bullous Pemphigoid and Drug Eruptions

• Bullous pemphigoid associated with neurologic disease (dementia, Parkinson's), psychiatric disease, bedridden state, chronic polypharmacy; mortality linked to disease severity and to treatment itself.
• Drug eruptions: morbilliform/urticarial reactions common; elderly more prone to drug-induced autoimmune reactions (bullous pemphigoid, lupus erythematosus, pemphigus); risk increased by polypharmacy and age-related decline in renal/cardiac/hepatic drug metabolism and excretion — emphasizes careful medication review.

F. Ulcers

• Compromised wound repair + comorbidities (diabetes, atherosclerotic PVD) predispose to chronic leg ulcers.
• Chronic venous insufficiency → venous hypertension → fibrinogen/macromolecule leakage into dermis → impaired oxygen/nutrient/growth factor delivery.
• Lipodermatosclerosis (lower-extremity panniculitis): indurated, brownish-red pigmented skin; tissue hypoxia, cytokine activation, interstitial protein exudates.
• Decubitus (pressure) ulcers: due to age-related skin atrophy from elevated MMPs + decreased fibroblast collagen synthesis, plus reduced mobility, incontinence, malnutrition.

---

10. Management / Practical Approach (Chapter emphasis + standard adjuncts)

• Seborrheic keratoses/senile lentigines/cherry angiomas: reassurance; treat only for cosmesis or bleeding.
• Xerosis/asteatotic eczema: emollients, humidification, avoid harsh soaps/hot water.
• Pruritus/scabies: topical scabicides (permethrin), oral ivermectin, antihistamines for symptomatic relief.
• Infections: appropriate antibacterial/antifungal/antiviral therapy adjusted for comorbidities and drug metabolism.
• Drug eruptions: minimize polypharmacy, regular medication reconciliation, dose adjustment for renal/hepatic decline.
• Estrogen therapy: topical estrogen may improve intrinsically aged (sun-protected) skin thickness/collagen but has limited efficacy on already photoaged skin.

• Photoprotection — broad-spectrum sunscreen, protective clothing, avoidance of peak UV hours — the single most effective preventive measure since extrinsic aging is largely UV-driven.
• Topical retinoids (tretinoin) — stimulate collagen synthesis, reduce fine wrinkling, improve dyspigmentation.
• Topical antioxidants (vitamin C, vitamin E, niacinamide) — counter oxidative stress/ROS.
• Alpha/beta-hydroxy acids, chemical peels — improve texture, dyspigmentation.
• Procedural options: laser resurfacing, microneedling, botulinum toxin (dynamic wrinkles), dermal fillers (volume loss), platelet-rich plasma.

---

Exam-Focused Key Points to Remember

1. Two aging pathways — intrinsic (genetic/hormonal, chronologic) vs extrinsic (environmental, mainly UV = photoaging) — with distinguishing histology (thinning + loss of rete ridges vs solar elastosis) and clinical signs (fine wrinkles/pallor vs deep wrinkles/telangiectasia/dyspigmentation).
2. Oxidative stress + telomere shortening are central unifying mechanisms of intrinsic aging.
3. MMP-collagen fragmentation cycle is the key molecular driver of photoaged dermal changes.
4. Estrogen improves intrinsically aged but not photoaged skin — a classic exam distinguishing point.
5. Know the geriatric dermatoses list: solar lentigines, seborrheic keratoses, senile (cherry) angiomas, xerosis, asteatotic eczema, pruritus — plus increased skin cancer risk and atypical infection presentations in the elderly.